Cargando…

Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

BACKGROUND: Genetic testing has potential roles in identifying whether an individual would have risk of adverse drug reactions (ADRs) from a particular medicine. Robust cost-effectiveness results on genetic testing would be useful for clinical practice and policy decision-making on allocating resour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turongkaravee, Saowalak, Jittikoon, Jiraphun, Rochanathimoke, Onwipa, Boyd, Kathleen, Wu, Olivia, Chaikledkaew, Usa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487501/ https://www.ncbi.nlm.nih.gov/pubmed/34600523 http://dx.doi.org/10.1186/s12913-021-07025-8

Ejemplares similares

Costs Associated with Adverse Drug Reactions Among HIV/TB Patients in Thailand
por: Rochanathimoke, Onwipa, et al.
Publicado: (2022)

Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV
por: Turongkaravee, Saowalak, et al.
Publicado: (2022)

Economic evaluation of prenatal screening for fetal aneuploidies in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy
por: Turongkaravee, Saowalak, et al.
Publicado: (2021)

Economic impact of medical genetic testing on clinical applications in Thailand
por: Jittikoon, Jiraphun, et al.
Publicado: (2020)

Economic cost of patients with trisomy 13, 18, and 21 in a tertiary hospital in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
por: Aungsumart, Saharat, et al.
Publicado: (2023)

Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2020)

Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in Thailand
por: Chitpim, Natthakan, et al.
Publicado: (2022)

GSTM1 and GSTT1 genetic polymorphisms and their association with antituberculosis drug-induced liver injury
por: Chanhom, Noppadol, et al.
Publicado: (2020)

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment
por: Yoopetch, Panida, et al.
Publicado: (2022)

Cartilage oligomeric matrix protein as a marker of progressive liver fibrosis in biliary atresia
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2021)

Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2021)

CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients
por: Chanhom, Noppadol, et al.
Publicado: (2021)

Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis
por: Yoopetch, Panida, et al.
Publicado: (2023)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Host genetic polymorphisms involved in long-term symptoms of COVID-19
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2023)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines
por: Briones, Jamaica Roanne, et al.
Publicado: (2020)

The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
por: Katanyoo, Kanyarat, et al.
Publicado: (2021)

The economic impact of alcohol consumption: a systematic review
por: Thavorncharoensap, Montarat, et al.
Publicado: (2009)

Clusterin exacerbates interleukin-1β-induced inflammation via suppressing PI3K/Akt pathway in human fibroblast-like synoviocytes of knee osteoarthritis
por: Ungsudechachai, Tachatra, et al.
Publicado: (2022)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
por: Piatkov, Irina, et al.
Publicado: (2012)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Meta-analysis of economic evaluation studies: data harmonisation and methodological issues
por: Bagepally, Bhavani Shankara, et al.
Publicado: (2022)

Pharmacogenetics for severe adverse drug reactions induced by molecular‐targeted therapy
por: Udagawa, Chihiro, et al.
Publicado: (2020)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

The economic costs of alcohol consumption in Thailand, 2006
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010)

Social and economic burden of patients with influenza-like illness and clinically diagnosed flu treated at various health facilities in Vietnam
por: Quang Vo, Trung, et al.
Publicado: (2017)

Economic evaluation of population-based type 2 diabetes mellitus screening at different healthcare settings in Vietnam
por: Toi, Phung Lam, et al.
Publicado: (2021)

Economic evaluation of hepatitis A vaccines by income level of the country: A systematic review
por: Gurav, Yogesh Kirshnarao, et al.
Publicado: (2022)

Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions
por: Chen, Zhibin, et al.
Publicado: (2014)

The Association of HLA-B*35 and GSTT1 Genotypes and Hepatotoxicity in Thai People Living with HIV
por: Chanhom, Noppadol, et al.
Publicado: (2022)

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
por: Merino, Diane, et al.
Publicado: (2022)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2020)

The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis
por: Lukkunaprasit, Thitiya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_46fepctsltgbqqeofa2nbja5c5